Tattooing is a more effective way of administering DNA vaccines than direct injection

Tattooing is a more effective way of administering DNA vaccines than direct injection into muscle tissue, according to new research by German and Czech scientists. In DNA vaccination, a gene from a pathogen is injected directly into the host, which then produces the corresponding pathogen protein inside its own cells. This triggers a response from the host's immune system. Advantages of DNA vaccination include the fact that the vectors can be constructed quickly, and rapid and large scale vaccine production is much cheaper than for traditional vaccines. These vaccines are also temperature stable; in contrast many traditional vaccines require cold storage and have a limited lifetime.

In this latest piece of research, the scientists compared tattoo delivery with intramuscular injection, both with and without the use of additional adjuvants, which are designed to boost the immune response of the vaccine. Their results are published in the journal Genetic Vaccines and Therapy.

The tattoo method gave a much stronger antibody and cellular response than intramuscular injection. Three doses of DNA vaccine delivered via tattooing elicited antibody levels 16 times higher than three intramuscular injections with adjuvant. The scientists also found that while adjuvants boosted the immune response for intramuscular vaccinations, they had no effect on DNA vaccinations.

The process of tattooing causes a wound and sufficient inflammation to 'prime' the immune system. Furthermore, it covers a larger area of the skin than an injection, allowing the DNA vaccine to get into more cells. The researchers speculate that these factors could contribute to the efficacy of tattooing as a vaccine delivery method.

"Vaccination with naked DNA has been hampered by its low efficiency," commented Martin Müller of the German Cancer Research Centre (DKFZ), who led the research. "Delivery of DNA via tattooing could be a way for a more widespread commercial application of DNA vaccines."

While acknowledging that tattooing may not be acceptable for everyone - the procedure is rather painful - the scientists believe it could have applications for the routine vaccine of livestock, or for delivering therapeutic (as opposed to preventive) vaccines in people. "Nevertheless, DNA vaccination via tattoo seems to be the method of choice if faster and stronger immune responses have to be achieved," the researchers conclude.

Advantages of the tattoo method include the low cost of the tattooing device and a standardised method for the application. On the down side, the researchers cite the strain on the animals and a 'somewhat cumbersome application procedure'.

Tattooing is already in use in some medical research applications where it is used to deliver materials to the skin, for example for scar treatments. It is also used to study the processes involved in cosmetic tattooing, or to deliver DNA for prospective gene therapy of skin disorders.

For more information, please visit:
http://www.gvt-journal.com/content/6/1/4

Copyright ©European Communities, 2008
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Salvat Laboratories announces submission of New Dr…

Salvat Laboratories announced that it has submitted a New Drug Application (NDA) to the FDA for the approval of the first ocular corticosteroid formulated in a nanoemulsi...

Pfizer's elranatamab granted FDA Breakthrough Ther…

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administrati...

New insights on antibody responses to Omicron vari…

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research quest...

Ancient viral DNA in human genome guards against i…

Viral DNA in human genomes, embedded there from ancient infections, serve as antivirals that protect human cells against certain present-day viruses, according to new res...

The origin-of-life molecule, a key to cancer resea…

RNA, the molecule that gave rise to life, has been shown to be essential for repairing human genetic material and preventing mutations that might lead to developing cance...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...